Inovio Pharma (INO) Tops Q2 EPS by 19c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.22 +2.52%
EPS Growth %: +60.7%
Financial Fact:
Research and development: 26.98M
Today's EPS Names:
CRMT, More
EPS Growth %: +60.7%
Financial Fact:
Research and development: 26.98M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of $, $0.19 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $16.29 million.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Rivian raises 2026 delivery outlook after Q2 results top guidance
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
